Cimicifuga racemosa treatment and health related quality of life in post-menopausal Spanish women

Gynecological Endocrinology

Volumn 25, Issue 1, 2009, Pages 21-26

  Mollá, Maria Dolores Juliá ^a   García Sánchez, Yolanda ^a   Sarrió, Alberto Romeu ^a   Pérez López, Faustino R ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Black cohosh; Cervantes Quality of Life Scale; Cimicifuga racemosa; Menopause; Obesity; Overweight; Post menopausal women; Quality of life

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SEXUALITY; SPAIN; TREATMENT DURATION; TREATMENT OUTCOME;

BODY MASS INDEX; CIMICIFUGA; FAMILY RELATIONS; FEMALE; HEALTH STATUS; HUMANS; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; QUALITY OF LIFE; SEXUALITY; SPAIN;

EID: 60749100718     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802404005     Document Type: Article

References (43)

1. Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
2. Beral V, Million Women Study Collaborators, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369:1703-1710.
3. Canonico M, Plu-Bureau G, Lowe GDO, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008;336:1227-1231.
4. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, et al. WHI Investigators Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008;299:1036-1045.
5. Winterhoff H, Spengler B, Christoffel V, Butterweck V, Löhning A. Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity. Maturitas 2003;44 (Suppl 1):S51-S58.
6. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005;106:1074-1083.
7. Viereck V, Gründker C, Friess SC, Frosch KH, Raddatz D, Schoppet M, Nisslein T, Emons G, Hofbauer LC. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. J Bone Miner Res 2005;20:2036-2043.
8. Freudenstein J, Dasenbrock C, Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Res 2002;62:3448-3452.
9. Garita-Hernández M, Calzado MA, Caballero FJ, Macho A, Muñoz E, Meier B, Brattström A, Fiebich BL, Appel K. The growth inhibitory activity of the Cimicifuga racemosa extract Ze 450 is mediated through estrogen and progesterone receptors-independent pathways. Planta Med 2006;72:317-323.
10. Stute P, Nisslein T, Götte M, Kamischke A, Kiesel L, Klockenbusch W. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro. Maturitas 2007;57:382-391.
11. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res 1976;20:425-430.
12. Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause 2002;9:402-410.
13. Palacios S, Ferrer-Barriendos J, Parrilla JJ, Castelo-Branco C, Manubens M, Alberich X, Martí A; Grupo Cervantes Health-related quality of life in the Spanish women through and beyond menopause Development and validation of the Cervantes Scale. Med Clin (Barc) 2004;122:205-211.
14. Genazzani AR, Nicolucci A, Campagnoli C, Crosignani P, Nappi C, Serra GB, Bottiglioni E, Cianci A, De Aloysio D, Sarti CD, et al.; Progetto Donna Qualità della Vita Working Group Novo Nordisk Italia. Validation of Italian version of the Women's Health Questionnaire: assessment of quality of life of women from the general population and those attending menopause centers. Climacteric 2005;5:70-77.
15. Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007;56:45-53.
16. Zöllner YF, Acquadro C, Schaefer M. Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res 2005;14:309-327.
17. Schwarz S, Völzke H, Alte D, Schwahn C, Grabe HJ, Hoffmann W, John U, Dören M. Menopause and determinants of quality of life in women at midlife and beyond: the study of health in Pomerania (SHIP). Menopause 2007;14:123-134.
18. Llaneza P, Iñarrea J, González C, Alonso A, Arnott I, Ferrer-Barriendos J. Differences in health related quality of life in a sample of Spanish menopausal women with and without obesity. Maturitas 2007;58:387-394.
19. Laferrère B, Zhu S, Clarkson JR, Yoshioka MR, Krauskopf K, Thornton JC, Pi-Sunyer FX. Race, menopause, health-related quality of life, and psychological well-being in obese women. Obes Res 2002;10:1270-1275.
20. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D; Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134.
21. Schilling C, Gallicchio L, Miller SR, Langenberg P, Zacur H, Flaws JA. Relation of body mass and sex steroid hormone levels to hot flushes in a sample of mid-life women. Climacteric 2007;10:27-37.
22. Division of Mental Health and Prevention of Substance Abuse, World Health Organization. Programme on Mental Health, World Health Organization annotated bibliography of the WHOQOL. WHO; 1998, pp. 1-32.
23. Gelfand MM, Moreau M, Ayotte NJ, Hilditch JR, Wong BA, Lau CY. Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. Menopause 2003;10:29-36.
24. Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Genazzani A. Effects of low-dose, continous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003;44:157-163.
25. Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ. The influence of tibolone on quality of life in postmenopausal women. Maturitas 2002;41:35-43.
26. Palacios S, Rojo IA, Cancelo MJ, Neyro JL, Castelo-Branco C. Women's perception of the efficacy of a soy extract with probiotic: the M3 study. Gynecol Endocrinol 2008;24:178-183.
27. Llaneza P, González C, Fernández-Iñarrea J, Alonso A, Arnott I, Ferrer-Barriendos J. Insulin resístance and health related quality of life in post-menopausal women. Fertil Steril, in press.
28. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86.
29. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 2005;3:47.
30. Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166:1262-1268.
31. Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause 2007;14:308-315.
32. Guallar-Castillón P, López García E, Lozano Palacios L, Gutiérrez-Fisac JL, Banegas Banegas JR, Lafuente Urdinguio PJ, Rodriguez Artalejo F. The relationship of overweight and obesity with subjective health and use of health-care services among Spanish women. Int J Obes Relat Metab Disord 2002;26:247-252.
33. Jones GL, Sutton A. Quality of life in obese postmenopausal women. Menopause Int 2008;14:26-32.
34. Nappi R, Malavasi R, Brundu B, Facchinetti F. Efficaccy of Cimicifuga racemosa on climateric complaints: A randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 2005;20:30-35.
35. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 2008;15:51-58.
36. Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, Van Breemen RB, Farnsworth NR, Bolton JL. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003;51:5661-5670.
37. Huntley A, Ernst E. A systematic review of the safety of black cohosh. Menopause 2003;10:58-64.
38. Wutke W, Seidlová-Wutke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. Conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44:S67-S77.
39. Oktem M, Eroglu D, Karahan HB, Taskintuna N, Kuscu E, Zeyneloglu HB. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther 2007;24:448-461.
40. Bland J. Does complementary and alternative medicine represent only placebo therapies? Altern Ther Health Med 2008;14:16-18.
41. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008;5:e45.
42. Whalley B, Hyland ME, Kirsch I. Consistency of the placebo effect. J Psychosom Res 2008;64:537-541.
43. Miller HG, Li RM. Measuring hot flashes: summary of a National Institutes of Health workshop. Mayo Clin Proc 2004;79:777-781.